François Chomy

1.6k total citations
29 papers, 727 citations indexed

About

François Chomy is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Physiology. According to data from OpenAlex, François Chomy has authored 29 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Oncology, 16 papers in Pulmonary and Respiratory Medicine and 6 papers in Physiology. Recurrent topics in François Chomy's work include Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Nutrition and Health in Aging (6 papers). François Chomy is often cited by papers focused on Lung Cancer Treatments and Mutations (12 papers), Lung Cancer Diagnosis and Treatment (6 papers) and Nutrition and Health in Aging (6 papers). François Chomy collaborates with scholars based in France, Germany and New Zealand. François Chomy's co-authors include Laurent Cany, C. Blanc-Bisson, Pierre Soubeyran, Jérôme Dauba, Carine Bellera, J. Ceccaldi, Nadine Houédé, Jean‐Frédéric Blanc, Alain Ravaud and Marianne Fonck and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

François Chomy

28 papers receiving 719 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
François Chomy France	11	304	251	239	217	69	29	727
Francovito Piantedosi Italy	7	507 1.7×	472 1.9×	124 0.5×	190 0.9×	42 0.6×	12	774
Marika Rasschaert Belgium	12	261 0.9×	109 0.4×	153 0.6×	209 1.0×	74 1.1×	32	545
Gábor Liposits Denmark	12	373 1.2×	162 0.6×	103 0.4×	128 0.6×	44 0.6×	48	586
Laëtitia Stefani France	12	275 0.9×	200 0.8×	95 0.4×	137 0.6×	43 0.6×	30	637
Santi Barbera Italy	10	632 2.1×	456 1.8×	106 0.4×	148 0.7×	72 1.0×	17	978
Lorenzo Dottorini Italy	13	330 1.1×	143 0.6×	167 0.7×	80 0.4×	133 1.9×	42	664
I. Boler United States	5	388 1.3×	219 0.9×	257 1.1×	463 2.1×	48 0.7×	8	832
J.-M. Bréchot France	9	273 0.9×	298 1.2×	146 0.6×	74 0.3×	108 1.6×	34	794
Øystein Fløtten Norway	14	626 2.1×	528 2.1×	336 1.4×	195 0.9×	122 1.8×	33	1.1k
Christophe Locher France	16	511 1.7×	416 1.7×	155 0.6×	139 0.6×	37 0.5×	32	1.1k

Countries citing papers authored by François Chomy

Since Specialization

Citations

This map shows the geographic impact of François Chomy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by François Chomy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites François Chomy more than expected).

Fields of papers citing papers by François Chomy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by François Chomy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by François Chomy. The network helps show where François Chomy may publish in the future.

Co-authorship network of co-authors of François Chomy

This figure shows the co-authorship network connecting the top 25 collaborators of François Chomy. A scholar is included among the top collaborators of François Chomy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with François Chomy. François Chomy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bessede, Alban, Florent Peyraud, Sylvestre Le Moulec, et al.. (2023). Upregulation of Indoleamine 2,3-Dioxygenase 1 in Tumor Cells and Tertiary Lymphoid Structures is a Hallmark of Inflamed Non–Small Cell Lung Cancer. Clinical Cancer Research. 29(23). 4883–4893. 12 indexed citations

Bessede, Alban, Florent Peyraud, Benjamin Besse, et al.. (2023). TROP2 Is Associated with Primary Resistance to Immune Checkpoint Inhibition in Patients with Advanced Non–Small Cell Lung Cancer. Clinical Cancer Research. 30(4). 779–785. 20 indexed citations

Italiano, Antoîne, Laura Leroy, Jean‐Philippe Guégan, et al.. (2023). TROP2 expression and response to immune checkpoint inhibition in patients with advanced non-small cell lung cancer.. Journal of Clinical Oncology. 41(16_suppl). 9040–9040. 2 indexed citations

Mathoulin‐Pélissier, Simone, H. Charitansky, Yann Godbert, et al.. (2023). Evaluating video-based consultations in routine clinical practice at a comprehensive cancer center. Acta Oncologica. 62(12). 1905–1912. 1 indexed citations

Béchade, Dominique, Carine Bellera, Pippa McKelvie‐Sebileau, et al.. (2022). Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies. Clinics and Research in Hepatology and Gastroenterology. 46(5). 101912–101912. 2 indexed citations

Palussière, Jean, Sophie Cousin, Mathilde Cabart, et al.. (2021). Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?. Current Oncology Reports. 23(7). 81–81. 14 indexed citations

Bilous, Mariia, Cindy Serdjebi, Alexandre Boyer, et al.. (2019). Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer. Scientific Reports. 9(1). 13018–13018. 20 indexed citations

Palussière, Jean, François Chomy, M. Savina, et al.. (2018). Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial. Journal of Cardiothoracic Surgery. 13(1). 91–91. 66 indexed citations

Robain, Mathieu, M. Pérol, Nicolas Girard, et al.. (2018). Programme épidémio-stratégie médicoéconomique : une base nationale de données de vie réelle pour mieux comprendre la prise en charge du cancer bronchopulmonaire en France. Revue des Maladies Respiratoires. 35. A106–A106.

10.

Bourdel‐Marchasson, Isabelle, C. Blanc-Bisson, A. Doussau, et al.. (2014). Nutritional Advice in Older Patients at Risk of Malnutrition during Treatment for Chemotherapy: A Two-Year Randomized Controlled Trial. PLoS ONE. 9(9). e108687–e108687. 98 indexed citations

11.

Palussière, Jean, Philippe Lagarde, Anne Aupérin, et al.. (2014). Percutaneous Lung Thermal Ablation of Non-surgical Clinical N0 Non-small Cell Lung Cancer: Results of Eight Years’ Experience in 87 Patients from Two Centers. CardioVascular and Interventional Radiology. 38(1). 160–166. 45 indexed citations

12.

Bourdel‐Marchasson, I., J. Durrieu, A. Doussau, et al.. (2013). PP111-SUN THE EFFECTS OF NUTRITIONAL ADVICES IN OLDER PATIENTS AT RISK FOR MALNUTRITION DURING CHEMOTHERAPY FOR CANCER ON THE QUALITY OF INTAKES. MULTICENTRE INOGAD STUDY. Clinical Nutrition. 32. S64–S64. 1 indexed citations

13.

Soubeyran, Pierre, Marianne Fonck, C. Blanc-Bisson, et al.. (2012). Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer. Journal of Clinical Oncology. 30(15). 1829–1834. 305 indexed citations

14.

Béchade, Dominique & François Chomy. (2012). Place de l'échoendoscopie œsophagienne (EUS) et bronchique (EBUS) dans l'évaluation des adénopathies médiastinales. Bulletin du Cancer. 99(7-8). 761–770. 2 indexed citations

15.

Palussière, Jean, E. Descat, Marianne Fonck, et al.. (2009). Traitement par radiofréquence des tumeurs hépatiques et pulmonaires. Bulletin du Cancer. 96(11). 1099–1109. 1 indexed citations

16.

Trédaniel, Jean, Catherine Becht, Hubert de Crémoux, et al.. (2008). An open phase II trial of gemcitabine, oxaliplatin and vinorelbine combination as first-line therapy in advanced non-small cell lung cancer patients. Lung Cancer. 63(2). 259–263. 4 indexed citations

17.

Trédaniel, Jean, Catherine Becht, Stéphane Culine, et al.. (2006). A multicentric phase II trial of gemcitabine (Gem), oxaliplatin (Oxa) and vinorelbine (VNB) in untreated stage IIIB and IV non-small cell lung cancer (NSCLC) patients (pts): Preliminary results of GON triplet regimen. Journal of Clinical Oncology. 24(18_suppl). 17104–17104. 1 indexed citations

18.

Pujol, Jean-Louis, Jean‐Yves Douillard, Alain Rivière, et al.. (1997). Dose-intensity of a four-drug chemotherapy regimen with or without recombinant human granulocyte-macrophage colony-stimulating factor in extensive-stage small-cell lung cancer: a multicenter randomized phase III study.. Journal of Clinical Oncology. 15(5). 2082–2089. 56 indexed citations

19.

Manegold, C., H. Wilke, François Chomy, et al.. (1997). Ifosfamide and gemcitabine in advanced non-small cell lung cancer (NSCLC). Lung Cancer. 18. 156–156. 2 indexed citations

20.

Ravaud, Alain, E. Legrand, M. Delaunay, et al.. (1995). A phase I trial of repeated tumour-infiltrating lymphocyte (TIL) infusion in metastatic melanoma. British Journal of Cancer. 71(2). 331–336. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact